Agency has been maintaining the database for adverse drug reactions observed in Latvia since 2001, and since 2004 the reported information is being forwarded to the European Union database EudraVigilance for identification of new risks with medicines. Every year SAM analyses the information entered into the database in Latvia and the reporting activity in Latvia.
In 2018, the number of adverse drug reaction reports received in Latvia reached 659 (an increase by 12%), doctors and pharmacists submitted 42 reports, patients submitted 34 reports.
